Risk factors of disease progression detected at the time of screening
Alcohol consumption | n (%) |
AU intake per week | 2 (0-35) |
Patient distribution per AU intake per week | |
0-6 | 85 (71) |
7-14 | 16 (13) |
≥14 | 14 (12) |
Metabolic | |
Type 2 diabetes | 8 (6) |
Arterial hypertension | 46 (39) |
Dyslipidemia (triglycerides > 150 mg/dL, HDL< 40 mg/dL or need of lipid lowering drugs) | 51 (43) |
Overweight (BMI 25-30 kg/m2) | 45 (38) |
Obesity (BMI ≥30 kg/m2) | 10 (8) |
Combined risk factors | |
At least 1 potential metabolic risk factor for liver disease | 92 (77) |
Three or more metabolic risk factors with alcohol intake less than 14 units per week | 25 (21) |
At least 1 potential risk factor for liver disease (metabolic or alcohol) | 96 (81) |
Alcohol consumption | n (%) |
AU intake per week | 2 (0-35) |
Patient distribution per AU intake per week | |
0-6 | 85 (71) |
7-14 | 16 (13) |
≥14 | 14 (12) |
Metabolic | |
Type 2 diabetes | 8 (6) |
Arterial hypertension | 46 (39) |
Dyslipidemia (triglycerides > 150 mg/dL, HDL< 40 mg/dL or need of lipid lowering drugs) | 51 (43) |
Overweight (BMI 25-30 kg/m2) | 45 (38) |
Obesity (BMI ≥30 kg/m2) | 10 (8) |
Combined risk factors | |
At least 1 potential metabolic risk factor for liver disease | 92 (77) |
Three or more metabolic risk factors with alcohol intake less than 14 units per week | 25 (21) |
At least 1 potential risk factor for liver disease (metabolic or alcohol) | 96 (81) |
BMI, body mass index.